Description

BSE circular detailing the listing of new equity shares for Novelix Pharmaceuticals Limited with lock-in periods.

Summary

BSE has listed new equity shares of Novelix Pharmaceuticals Limited. The circular provides details of 19 tranches of equity shares totaling 26,35,000 shares with distinctive numbers ranging from 9950001 to 12935000.

Key Points

  • Total of 26,35,000 new equity shares listed
  • 19 separate tranches with varying quantities from 10,000 to 15,00,000 shares
  • Distinctive numbers allocated from 9950001 to 12935000
  • All shares subject to lock-in periods

Regulatory Changes

No regulatory changes mentioned in this circular.

Compliance Requirements

  • Securities are subject to lock-in periods as specified
  • Trading restrictions apply until lock-in end dates

Important Dates

  • Lock-in end dates vary:
    • Most tranches: March 30, 2026
    • Some tranches: March 31, 2026
    • One tranche: March 30, 2027

Impact Assessment

Minimal market impact as this is a routine listing of new securities for a single company. The lock-in periods ensure gradual market availability of these shares.

Impact Justification

Routine listing of securities with standard lock-in periods affecting single company